|
Pembrolizumab, Sintilimab Clinical Trials
0 actively recruiting trials
No change since May 2026
Also known as: time-of-day of administration of immunochemotherapy
No trials match the selected filters.
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.